ADC payload with a differentiated mechanism of action; Combines oncology expertise of Novartis with Myricx Bio’s ...

Novartis has agreed to acquire Myricx Bio, a London-based developer of next-generation antibody-drug conjugates (ADCs), for ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Daykin, Nebraska (Photo by: Jim West/UCG/Universal Images Group via Getty Images) For ...

Pivot Bio, one of the world’s leading agtech companies, today announced the launch of Pivot Pathways: A Generation Grant, a new initiative designed to invest in the next generation of farm families, ...

After rolling out E20 petrol, the Centre is preparing the next phase of its biofuel strategy by planning to allow blending of ...

Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...

Management to participate in investor meetings on July 14-15 in BostonDenver, CO, July 10, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc.

Novartis has agreed to acquire Myricx Bio, a privately held UK-based biotechnology company developing a new class of antibody ...

Transform the subject from the input image into appealing claymation character, keep likeness. Handmade plasticine style, ...

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced that Carol Lou will retire as President and Chief Executive Officer of Takara Bio USA on July 10 ...

"It looks like I'm taking the trophy home" WOOO CHILE THOSE ARE FIGHTIN WORDS ? Full video out now, link in bio ?️ ...

Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...